GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 37 filers reported holding GT BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,799 | -22.7% | 32,347 | 0.0% | 0.00% | – |
| Q2 2023 | $10,092 | -43.3% | 32,347 | 0.0% | 0.00% | – |
| Q1 2023 | $17,791 | -39.1% | 32,347 | -1.9% | 0.00% | – |
| Q4 2022 | $29,199 | -49.7% | 32,967 | 0.0% | 0.00% | – |
| Q3 2022 | $58,000 | -50.8% | 32,967 | -16.1% | 0.00% | – |
| Q2 2022 | $118,000 | -75.0% | 39,310 | -76.0% | 0.00% | – |
| Q1 2022 | $472,000 | -9.2% | 163,790 | -3.9% | 0.00% | – |
| Q4 2021 | $520,000 | -53.9% | 170,455 | +2.0% | 0.00% | – |
| Q3 2021 | $1,127,000 | -67.8% | 167,095 | -25.9% | 0.00% | -100.0% |
| Q2 2021 | $3,495,000 | +1387.2% | 225,457 | +555.6% | 0.00% | – |
| Q1 2021 | $235,000 | – | 34,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |